UNSPSC 51171967: Timoprazole

This classification denotes a proton pump inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 95H6S1X9CC. European Medicines Agency schedules Timoprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11071MIG. Timoprazole generally arises in the molecular formula C13H11N3OS.

UNSPSC 51171967 Timoprazole is a Commodity code that encompasses pharmaceutical active pharmaceutical ingredients and finished-dose medications supplied to state and local health, corrections, and human services agencies. Recent state and local solicitations under this code show demand for specimen collection and drug-testing services incorporating pharmaceutical screening methodologies, direct-to-manufacturer pharmaceutical distribution models, and generic multi-source pharmaceutical procurement through cooperative purchasing vehicles. State and local buyers include county corrections departments, state health and human services commissions, and multi-state cooperative purchasing alliances serving government facilities. The work solicited ranges from operational drug-testing programs with onsite collection and lab confirmation to strategic pharmacy benefit initiatives and bulk pharmaceutical supply agreements negotiated through authorized wholesalers.

Activity clusters in Texas and Minnesota. Collin County Community Supervision and Corrections Department (Texas) posted RFP 2026-327 on July 9, 2026, due July 23, 2026, for offender specimen collection and drug testing services with annual testing demand of approximately 25,031 tests, an estimated contract value of $600,000, and a two-year term with optional renewals through September 1, 2026. The Texas Health and Human Services Commission issued Request for Information HHS0017013 in late March 2026 (deadline April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program aimed at improving prescription fulfillment efficiency and cost management outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), posted RFP S1070000015802 on January 20, 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) to participating state and local government facilities in Minnesota and Oregon, with contract term effective July 1, 2026.